Key Points Wall Street has a much more positive price target for this Chinese AI stock than it does for Nvidia or Palantir.Analysts like the Chinese company's business and its attractive stock ...

Duquesne Family Office's billionaire chief dumped his fund's stake in Wall Street's artificial intelligence (AI) darling in ...

Palantir Technologies' advanced data mapping and AI solutions give it a strong moat and impressive profitability. Click here ...

Mizuho Securities has upgraded Palantir (NASDAQ:PLTR) from Underperform to Neutral after the company's revenue growth ...

Palantir Technologies (PLTR) has recently forged partnerships with Knightscope Inc. for entry into the U.S. federal marketplace and with Velocity Clinical Research to enhance clinical trial efficiency ...

Felix Wintle, manager of the VT Tyndall North American Fund, highlights three favourite US stocks where he'd put his money ...

Symbotic's revenue soared 40% year over year in the second quarter of fiscal 2025. That's slightly higher than Palantir's revenue growth in its latest quarter. Unlike Palantir, though, Symbotic ...

Goldman Sachs projects a 50% surge in global datacenter demand by 2027 as Meta, Palantir and Amazon ramp up AI infrastructure ...

This is just the beginning. The AI software market is on track to grow at a healthy pace over the next five years, and ...

With a strong brand and a mover advantage, the company seems positioned to benefit from the broader AI wave. However, beneath ...

At 40x forward earnings, AMD & Nvidia seem similar. But Nvidia has 58% margins, 86% revenue growth & $43B in net cash, while ...

Raghu Punnamraju, Velocity Clinical Research Chief Technology Officer ...